Skip to main content
Navigate Up
Sign In
 

New Drug Could Help Those With Tough-to-Treat Cholesterol


“It suggests that adding ezetimibe, which is typically an 18 to 20 percent reduction, to bempedoic acid only produces a modest additional benefit,” said Robert Eckel, who holds an endowed chair in atherosclerosis at the CU School of Medicine. “It’s not like the 40 percent you would expect.”
 

U.S. News & World Report, March 14, 2019

Read more